JP Morgan Chase
IMCR icon

JP Morgan Chase’s Immunocore IMCR Stock Holding History

JP Morgan Chase’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Sell
3,415
-106
-3% -$3.14K ﹤0.01% 6013
2026
Q1 		$103K Sell
3,521
-178
-5% -$5.76K ﹤0.01% 5816
2025
Q4 		$128K Buy
3,699
+494
+15% +$17.4K ﹤0.01% 5761
2025
Q3 		$116K Buy
3,205
+542
+20% +$18.4K ﹤0.01% 5811
2025
Q2 		$83.6K Sell
2,663
-542
-17% -$16.8K ﹤0.01% 5687
2025
Q1 		$95.1K Sell
3,205
-443
-12% -$13.3K ﹤0.01% 5592
2024
Q4 		$108K Sell
3,648
-890
-20% -$28.1K ﹤0.01% 5729
2024
Q3 		$141K Sell
4,538
-6,737
-60% -$245K ﹤0.01% 5558
2024
Q2 		$382K Buy
11,275
+3,567
+46% +$182K ﹤0.01% 4829
2024
Q1 		$501K Sell
7,708
-93,374
-92% -$6.41M ﹤0.01% 4796
2023
Q4 		$6.91M Buy
101,082
+36,300
+56% +$1.89M ﹤0.01% 2815
2023
Q3 		$3.36M Buy
64,782
+3,238
+5% +$192K ﹤0.01% 3135
2023
Q2 		$3.69M Buy
61,544
+4,814
+8% +$275K ﹤0.01% 3100
2023
Q1 		$2.81M Sell
56,730
-56,749
-50% -$3.19M ﹤0.01% 3287
2022
Q4 		$6.48M Buy
113,479
+101,271
+830% +$5.7M ﹤0.01% 2615
2022
Q3 		$573K Sell
12,208
-898
-7% -$42.8K ﹤0.01% 4365
2022
Q2 		$489K Buy
+13,106
New +$426K ﹤0.01% 4581

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

JP Morgan Chase's IMCR Position: Q2 2026 in Review

JP Morgan Chase reduced its Immunocore (IMCR) stake by 3% in Q2 2026, selling an estimated $3.14K and leaving 3,415 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #6013.

JP Morgan Chase first reported a position in IMCR in Q2 2022 and has held it in 17 quarters since. The position peaked at $6.91M in Q4 2023. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • JP Morgan Chase held 3,415 shares of Immunocore worth $104K as of Q2 2026.
  • JP Morgan Chase sold 106 Immunocore shares in Q2 2026, an estimated $3.14K.
  • Immunocore made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6013 holding.
  • JP Morgan Chase first reported a position in Immunocore in Q2 2022 and has held it in 17 quarters since.
  • JP Morgan Chase's Immunocore position peaked at $6.91M in Q4 2023.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.